BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35354463)

  • 21. Screening History Among Women with Invasive Cervical Cancer in an Academic Medical Center: Will We Miss Cancers Following Updated Guidelines?
    Nitschmann C; May T; Mirkovic J; Feldman S
    J Womens Health (Larchmt); 2016 Aug; 25(8):826-31. PubMed ID: 26859535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of cervical cancer: screening, progress and perspectives].
    Monsonego J
    Presse Med; 2007 Jan; 36(1 Pt 2):92-111. PubMed ID: 17296477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of cervical cancer risk-factors in women referred to Yazd-Iran hospitals from 2002 to 2009.
    Karimi Zarchi M; Akhavan A; Gholami H; Dehghani A; Naghshi M; Mohseni F
    Asian Pac J Cancer Prev; 2010; 11(2):537-8. PubMed ID: 20843147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in awareness of cervical cancer patients after medical treatments and the correlation of cervical screening situation and clinical stage at consultation].
    Wang CF; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):361-3. PubMed ID: 22883525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of invasive cervical cancer in pregnancy: clinical analysis of 13 cases].
    Guo Q; Shan Y; Yang JX; Liu JT; Cao DY; Cheng NH; Huang HF; Pan LY; Lang JH; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):893-7. PubMed ID: 23324187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
    Sumarmi S; Hsu YY; Cheng YM; Lee SH
    Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of chlamydia and Pap-smear abnormalities in pregnant adolescents warrants routine screening.
    Quinlivan JA; Petersen RW; Gurrin LC
    Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):254-7. PubMed ID: 9761147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
    He Y; Wang Y; Ji C; Liu Y; Wu YM
    Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
    Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
    Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How useful are cervical Pap smears in detecting endometrial carcinomas? A tertiary cancer center experience.
    Mehta SP; Patel TS; Jana T; Samanta ST; Malvania R; Trivedi PP; Girdher S
    Diagn Cytopathol; 2021 Jan; 49(1):127-131. PubMed ID: 32910561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Review of cervical smears in a gynaecologic department after a period of ten years under the consideration of colposcopic findings(author's transl)].
    Michalzik K
    Arch Gynakol; 1975; 218(2):149-68. PubMed ID: 1174025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cancer screening: patients understanding in major hospitals in Malaysia.
    Othman NH; Devi BC; Halimah Y
    Asian Pac J Cancer Prev; 2009; 10(4):569-74. PubMed ID: 19827871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predicting disease outcome in early stage adenocarcinoma of the uterine cervix.
    Erzen M; Mozina A; Bertole J; Syrjänen K
    Eur J Obstet Gynecol Reprod Biol; 2002 Mar; 101(2):185-91. PubMed ID: 11858896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinicopathological study of postoperatively upgraded early squamous-cell carcinoma of the uterine cervix.
    Yoshida M; Jimbo H; Shirai T; Takahashi M; Shiromizu K; Kuwabara Y
    J Obstet Gynaecol Res; 2000 Aug; 26(4):259-64. PubMed ID: 11049235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does screening by "Pap" smears help prevent cervical cancer? A case-control study.
    Clarke EA; Anderson TW
    Lancet; 1979 Jul; 2(8132):1-4. PubMed ID: 87887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
    Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
    J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical Screening and Colposcopy Management of Women Age 24 and Under.
    Buick C; Jembere N; Wang L; Kupets R
    J Obstet Gynaecol Can; 2020 Dec; 42(12):1518-1524. PubMed ID: 32988802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
    Lawson HW; Henson R; Bobo JK; Kaeser MK
    MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.